Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Vernalis Collaborates with Unison to Discover Drugs for “Undruggable” Bacterial Target

publication date: Sep 6, 2022

Vernalis Research formed a research collaboration with Unison Medicines to design small molecules for an undisclosed, hard-to-target bacterial site. Vernalis is a Cambridge UK structure-based drug discovery company that was acquired by Chengdu HitGen in 2020.  Unison, a Cambridge, MA startup, develops novel drugs for drug resistant infections. Vernalis will use its drug discovery technology to find small molecules for the Unison target, which has previously been considered undruggable. Unison will finance Vernalis’ work and be responsible for paying milestones and royalties on any revenues. Vernalis contributed to Unison's first financing round. More details....

Stock Symbol: (SHA: 688222)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital